European heart journal. Quality of care & clinical outcomes · 2026
Current epidemiology and management of acute heart failure: the multicenter prospective OFICA2 cohort.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alos Benjamin, Bouleti Claire, Legallois Damien, Riocreux Clement, Costa Jerome, Puymirat Etienne, Trochu Jean-Noel, Turlotte Guillaume, Perrin-Faurie Julie, Dutoiu Teodora, Picard François, Ducrocq Gregory, de Groote Pascal, Laperche Thierry, Delmas Clement, Cohen Ariel, Doublet Maxime, Logeart Damien
Аннотация
AIMS: Acute heart failure (AHF) represents a major cause of morbi-mortality. In the last decade, the management of HF has changed, but up-to-date real-life data are scarce. The aim of our study was to describe contemporary data about AHF patients' medical pathway, management and to identify predictors of in-hospital outcomes.
METHODS AND RESULTS: OFICA2 is a French prospective multicenter cohort led from March to April 2021 in 80 participating centres. In-hospital outcomes were defined as a composite of all-cause death, cardiogenic shock or transfer to intensive care unit. A total of 1513 consecutive patients (mean age 76 years, 61% male) hospitalized for AHF were included. One in five patients was not admitted in cardiology wards. A triggering factor was identified in 70% of cases, mostly supraventricular arrhythmia (21%). Median hospital stay was 11 days, and in-hospital mortality was 4.6%. Predictive factors of worse outcomes were a younger age, an initial acute coronary syndrome, a ventricular arrhythmia, a left ventricular ejection fraction (LVEF) ≤ 40%, a lower systolic blood pressure, a worse kidney function, and a higher C-reactive protein level on admission. At discharge, 61% of patients had an appointment scheduled with a cardiologist, 1 out of 4 patients with LVEF ≤ 40% had a combination of beta-blocker, renin-angiotensin system blocker and mineralocorticoid receptor antagonist, while 12% had no HF medication.
CONCLUSION: This comprehensive survey about patients hospitalized with AHF emphasizes HF care pathway, medical therapies and follow-up as weak spots. Filling these gaps might improve patients' management and prognosis.
METHODS AND RESULTS: OFICA2 is a French prospective multicenter cohort led from March to April 2021 in 80 participating centres. In-hospital outcomes were defined as a composite of all-cause death, cardiogenic shock or transfer to intensive care unit. A total of 1513 consecutive patients (mean age 76 years, 61% male) hospitalized for AHF were included. One in five patients was not admitted in cardiology wards. A triggering factor was identified in 70% of cases, mostly supraventricular arrhythmia (21%). Median hospital stay was 11 days, and in-hospital mortality was 4.6%. Predictive factors of worse outcomes were a younger age, an initial acute coronary syndrome, a ventricular arrhythmia, a left ventricular ejection fraction (LVEF) ≤ 40%, a lower systolic blood pressure, a worse kidney function, and a higher C-reactive protein level on admission. At discharge, 61% of patients had an appointment scheduled with a cardiologist, 1 out of 4 patients with LVEF ≤ 40% had a combination of beta-blocker, renin-angiotensin system blocker and mineralocorticoid receptor antagonist, while 12% had no HF medication.
CONCLUSION: This comprehensive survey about patients hospitalized with AHF emphasizes HF care pathway, medical therapies and follow-up as weak spots. Filling these gaps might improve patients' management and prognosis.